Why This Matters
Founded by Nishant Kathpal, the fresh capital will help Ayati Devices accelerate the commercialization of its diagnostic technologies, strengthen manufacturing capabilities, and expand across domestic and international markets. The company will also increase investments in R&D and AI to advance its point-of-care screening solutions.
What's the Bigger Picture?
Portable and accessible diagnostic technologies are becoming increasingly important as healthcare systems seek earlier detection outside tertiary hospitals. Ayati Devices' presence across 30 countries and 10,000+ deployed devices highlight the growing demand for decentralized diagnostic solutions, particularly for chronic conditions such as diabetic foot complications and peripheral vascular disease.
Key Takeaways
Ayati Devices has raised ₹15 Cr in Pre-Series A funding led by Inflexor Ventures to accelerate the commercialization and global expansion of its point-of-care diagnostic technologies. The company will strengthen manufacturing, invest in AI and research, and expand access to early screening solutions across domestic and international markets.
